Laurent Chene
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
EB1010, a putative Christensenellaceae-derived microbial peptide, exhibits anti-inflammatory activity and therapeutic potential in ulcerative colitis.
Journal: Gut microbes
Published: April 25, 2026
OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.
Journal: Communications medicine
Published: February 23, 2026
Identification of immunoregulatory peptides from gut microbiota modulating Epstein-Barr virus-induced gene 3 (EBI3) using a novel specific AlphaLISA™ assay.
Journal: Methods (San Diego, Calif.)
Published: June 10, 2025
The gut microbiota protein BOC1 exhibits immune checkpoint inhibitor-like activity by inhibiting myeloid-derived suppressor cell differentiation.
Journal: Frontiers in immunology
Published: April 07, 2025
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.
Journal: Journal for immunotherapy of cancer
Published: January 28, 2025
Identification of a muropeptide precursor transporter from gut microbiota and its role in preventing intestinal inflammation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 21, 2023
Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease.
Journal: International journal of molecular sciences
Published: May 28, 2023
Fecal Microbiota Transplant from Human to Mice Gives Insights into the Role of the Gut Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD).
Journal: Microorganisms
Published: December 22, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026